Ajai Chari, MD
img_Ajai Chari
ADJUNCT PROFESSOR | Medicine, Hematology and Medical Oncology


Health Care Provider of the Year, Leukemia Lymphoma Society


Ewig Teaching Award, Deparatment of Medicine, Columbia University College of Physicians and Surgeons


Phi Beta Kappa, Stanford University

Best Junior Faculty Teacher Award, selected by 2008 Internal Medicine residency class, Columbia University College of Physicians and Surgeons

New York Metro Super Doctors 2011-2015

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Chari during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • secura bio
  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Pfizer Inc.
  • shattuck labs
  • spargo
  • westchester medical center
  • Epizyme, Inc.
  • Karyopharm Inc.
  • Eisai Inc.
  • MJH
  • AbbVie Inc.
  • International Myeloma Foundation (IMF)
  • Genentech, Inc.
  • Janssen Pharmaceuticals, Inc.
  • WebMD
  • Curio biosciences
  • sciterion
  • Millennium Pharmaceuticals, Inc. (Takeda Pharmaceutical Company Limited )
  • aptitude
  • Clinical Care Options, LLC (CCO)
  • Multiple Myeloma Research Foundation (MMRF)
  • DAVA Oncology, LP

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.